All Updates

All Updates

icon
Filter
Funding
Phase receives grant of USD 1.8 million from National Institutes of Health for microfluidic 3D-printing project
Additive Manufacturing
Feb 22, 2024
This week:
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Funding
OceanWell raises USD 11 million in Series A funding to build water farms
Conservation Tech
Yesterday
Product updates
H launches Runner H, an AI agent for business automation
Foundation Models
Yesterday
Partnerships
Capgemini partners with Mistral AI and Microsoft to expand GenAI solutions globally
Foundation Models
Yesterday
Funding
Product updates
Converge Bio launches biotech LLM platform with USD 5.5 million seed funding
Foundation Models
Yesterday
Partnerships
Snowflake partners with Anthropic to integrate Claude AI models into Cortex AI platform
Foundation Models
Yesterday
Product updates
DeepSeek releases AI reasoning model DeepSeek-R1
Foundation Models
Yesterday
Industry news
Partnerships
ICEYE partners with Lockheed Martin and Finnish firms to develop defense space technologies
Next-gen Satellites
Yesterday
Partnerships
Dematic installs AutoStore system at South West Healthcare logistics hub
Logistics Tech
Yesterday
Additive Manufacturing

Additive Manufacturing

Feb 22, 2024

Phase receives grant of USD 1.8 million from National Institutes of Health for microfluidic 3D-printing project

Funding

  • Phase Inc., a developer of 3D-printing medical devices for microfluidic organ-on-a-chip devices, has received a grant of USD 1.8 million from the National Institutes of Health for a 3D printing project with Georgia Tech, Harvard Medical School's Massachusetts General Hospital, and Virginia Tech.

  • The funds will be used to build on the work of its existing projects and to create a blood-brain barrier device designed to overcome the limitations of current brain models. 

  • Phase specializes in 3D-printed microfluidics, offering a proprietary platform that allows polydimethylsiloxane (PDMS) and other biocompatible materials to be printed at high resolution and scale. This supports customizable microfluidic device production, integrating valves, sensors, and electrodes during printing.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.